Background: Guidelines recommend that patients with coronary artery disease (CAD) carry
and immediately use acetylsalicylic acid (ASA) and sublingually administered nitroglycerin …

Background: Guidelines for coronary artery disease (CAD) recommend carrying and
immediately using acetylsalicylic acid (ASA) and sublingual nitroglycerin at the onset of …

Contemporary practice favors refilling sublingual nitroglycerin (SL NTG) every 3 to 6 months.
This recommendation is based on antiquated data that does not consider the reformulated …

Background Both chewed aspirin and sublingual nitroglycerin are fast acting medications
and reach therapeutic levels within a few minutes. Current guidelines for managing acute …

Objectives ACC/AHA/ESC guidelines recommend sublingual nitroglycerin (SNG) in patients
with stable angina pectoris and coronary artery disease (CAD). However, the shelf life of …

AIM: A number of evidence-based medications are recommended following an acute
coronary syndrome (ACS), including statins, antithrombotics (antiplatelet and/or …

Aim: To evaluate tolerability of a new extended-release acetylsalicylic acid (ER-ASA).
Materials & methods: Daily ER-ASA (162.5–1300 mg) for up to 6 weeks was evaluated (four …

Introduction The risk assessment process for new medicines procured into NHS Acute Trusts
varies between organisations. National guidance identifying categories of medicines …

During and immediately following a myocardial infarction, care providers routinely explain
the role of statins as a way to reduce the chance of further coronary events and even death …

Objective: While widely used in the treatment of cardiac conditions, only limited data
characterize out-of-hospital nitroglycerin (NTG) use. We sought to determine the safety of out …